3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Biopsy
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
larotrectinib
2
erdafitinib
2
ensartinib
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
palbociclib
1
olaparib
1
niraparib
1
ivosidenib
1
elacestrant
1
cabozantinib
1
alectinib
1
abemaciclib
1
Vincristine
1
Vinblastine
1
Vemurafenib
1
Topotecan
1
Temozolomide
1
RAD1901
1
Methotrexate
1
LY3023414
1
Induction Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
adavosertib
×
30 days
×
Clear all
No trials found.